![Riam Shammaa](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Riam Shammaa is the founder of IntelliStem Technologies, Inc. where he holds the title of Chief Executive Officer since 2019.
Dr. Shammaa is also the founder of Pallianera Pharma, Inc. Dr. Shammaa's current job is as an Independent Director at Defence Therapeutics Inc since 2021.
Riam Shammaa active positions
Companies | Position | Start |
---|---|---|
DEFENCE THERAPEUTICS INC. | Director/Board Member | 2021-11-08 |
IntelliStem Technologies, Inc.
![]() IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation. | Chief Executive Officer | 2019-02-03 |
Former positions of Riam Shammaa
Companies | Position | End |
---|---|---|
Pallianera Pharma, Inc. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
DEFENCE THERAPEUTICS INC. | Health Technology |
Private companies | 2 |
---|---|
IntelliStem Technologies, Inc.
![]() IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation. | Health Technology |
Pallianera Pharma, Inc. |
- Stock Market
- Insiders
- Riam Shammaa